Search Results - Paul Van Daele

Refine Results
  1. 1
    Autoantibodies in Sjögren's syndrome and its classification criteria

    Autoantibodies in Sjögren's syndrome and its classification criteria by Sharon Veenbergen, Ana Kozmar, Paul Van Daele, Marco W.J. Schreurs

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity

    How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity by Annemieke Smorenberg, Edgar Peters, Paul Van Daele, Esther J. Nossent, Majon Muller

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment

    Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment by Tim Both, Virgil A. S. H. Dalm, P. Martin van Hagen, Paul Van Daele

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Mast Cells in Cardiovascular Disease: From Bench to Bedside

    Mast Cells in Cardiovascular Disease: From Bench to Bedside by Maud A.W. Hermans, Jeanine E. Roeters van Lennep, Paul Van Daele, Ilze Bot

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Calcium and Vitamin D in Sarcoidosis: Is Supplementation Safe?

    Calcium and Vitamin D in Sarcoidosis: Is Supplementation Safe? by Lieke S. Kamphuis, Femke Bonte‐Mineur, Jan van Laar, P. Martin van Hagen, Paul Van Daele

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Successful treatment of CRPS 1 with anti-TNF

    Successful treatment of CRPS 1 with anti-TNF by Frank Huygen, Sjoerd P. Niehof, Freek J. Zijlstra, P. Martin van Hagen, Paul Van Daele

    Published 2004
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    Adalimumab: a new modality for Behcet's disease?

    Adalimumab: a new modality for Behcet's disease? by Jan A. M. van Laar, Tom Missotten, Paul Van Daele, Anna Jamnitski, G.S. Baarsma, P. Martin van Hagen

    Published 2006
    Get full text
    Carta
    Save to List
    Saved in:
  8. 8
    Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

    Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome by Anna M. Aalbers, Paul Van Daele, Virgil A. S. H. Dalm, Peter J.M. Valk, Marc H.G.P. Raaijmakers

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Risk Factors for Increased Bone Loss in an Elderly Population The Rotterdam Study

    Risk Factors for Increased Bone Loss in an Elderly Population The Rotterdam Study by Huibert Burger, Chris De Laet, Paul Van Daele, A. Weel, Jacqueline C.M. Witteman, Albert Hofman, Huibert A. P. Pols

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis

    The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis by Niels A.D. Guchelaar, Manon M. Waling, Anviti A. Adhin, Paul Van Daele, Marco W.J. Schreurs, Saskia M. Rombach

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Everything you need to know about distal renal tubular acidosis in autoimmune disease

    Everything you need to know about distal renal tubular acidosis in autoimmune disease by Tim Both, Robert Zietse, Ewout J. Hoorn, P. Martin van Hagen, Virgil A. S. H. Dalm, Jan van Laar, Paul Van Daele

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Imatinib mesylate in the treatment of systemic mastocytosis

    Imatinib mesylate in the treatment of systemic mastocytosis by Helga Droogendijk, Hanneke C. Kluin‐Nelemans, J. J. van Doormaal, Arnold P. Oranje, Arjan A. van de Loosdrecht, Paul Van Daele

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Vertebral deformities as predictors of non-vertebral fractures

    Vertebral deformities as predictors of non-vertebral fractures by Huibert Burger, Paul Van Daele, D. Algra, Albert Hofman, Diederick E. Grobbee, Henri E. Schütte, J.C. Birkenhäger, Huibert A. P. Pols

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Vertebral Deformities and Functional Impairment in Men and Women

    Vertebral Deformities and Functional Impairment in Men and Women by Huibert Burger, Paul Van Daele, K. Grashuis, Albert Hofman, Diederick E. Grobbee, H E Schütte, J. C. Birkenhäger, Huibert A. P. Pols

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis

    Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis by Laura Eurelings, Jelle Miedema, Virgil A. S. H. Dalm, Paul Van Daele, P. Martin van Hagen, Jan A. M. van Laar, Willem A. Dik

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

    Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study by Paul Van Daele, Markus J. Seibel, H Burger, Albert Hofman, Diederick E. Grobbee, Johannes P.T.M. van Leeuwen, J.C. Birkenhäger, H.A.P. Pols

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Azacytidine Treatment for VEXAS Syndrome

    Azacytidine Treatment for VEXAS Syndrome by Marc H.G.P. Raaijmakers, Maud A.W. Hermans, Anna M. Aalbers, Melissa Rijken, Virgil A. S. H. Dalm, Paul Van Daele, Peter J.M. Valk

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome

    Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome by Tim Both, Ewout J. Hoorn, Robert Zietse, Jan van Laar, Virgil A. S. H. Dalm, Zana Brkić, Marjan A. Versnel, P. Martin van Hagen, Paul Van Daele

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    The JAK1/JAK2‐ inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

    The JAK1/JAK2‐ inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release by Maud A.W. Hermans, Benjamin Schrijver, Conny C.P.A. van Holten‐Neelen, Roy Gerth van Wijk, P. Martin van Hagen, Paul Van Daele, Willem A. Dik

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density

    A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density by André G. Uitterlinden, Huibert A. P. Pols, Huibert Burger, Qiuju Huang, Paul Van Daele, Cornelia M. van Duijn, Albert Hofman, J.C. Birkenhäger, Johannes P.T.M. van Leeuwen

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: